Boston Scientific to acquire Relievant Medsystems for $850M
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Relievant Medsystems.
Stay updated with breaking news from Sam Eiber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Relievant Medsystems.
Analysts are playing down the potentially negative impact of GLP-1 receptor agonists on the diabetes technology industry.
Boston Scientific (NYSE: BSX) announced positive 12-month results from the trial of its Farapulse pulsed-field ablation (PFA) system.
Senseonics (NYSE:SENS) shares took a hit today on second-quarter results that missed the consensus sales forecast.
Operator: Good afternoon. Welcome to Establishment Labs’ Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.